Top compounds associated with response to TMEM39A


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA PX-12 CTRPv2 pan-cancer AAC -0.09 0.002
mRNA etoposide CTRPv2 pan-cancer AAC -0.089 0.003
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA SB-525334 CTRPv2 pan-cancer AAC -0.11 0.004
mRNA Topotecan CTRPv2 pan-cancer AAC -0.093 0.004
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.004
mRNA AEW541 CCLE pan-cancer AAC 0.13 0.005
Download CSV